NanoVector, Inc

A. Bender
NanoVector, Inc, US

Keywords: biotech, cancer treatment

Abstract:

NanoVector has licensed the plant virus nanoparticle drug delivery system and 2-stage targeting developed by Professors’ Stefan Franzen and Steven Lommel from North Carolina State University.